FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

GlaxoSmithKline related Press Releases

GSK Upbeat on Solid Results - Interviews with CEO and CFO

Posted February 7, 2012

LONDON, February 7, 2012 /PRNewswire/ -- In an online video interview with MerchantCantos, GlaxoSmithKline CEO Sir Andrew Witty talks about the pharmaceutical group's special dividend, solid results Read more...

Prosensa Raises €23 Million in New Equity Financing Led by New Enterprise Associates

Posted January 25, 2012

LEIDEN, Netherlands--(BUSINESS WIRE)-- Prosensa, the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet needs, announced today that it has Read more...

Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson's Disease

Posted December 21, 2011

Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson's Disease HAYWARD, Calif.--(BUSINESS WIRE)--Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. Read more...

GSK receives initial data from the first completed phase lll study of albiglutide in type 2 diabetes

Posted November 16, 2011

GSK receives initial data from the first completed phase lll study of albiglutide in type 2 diabetes Issued: Wednesday 16 November 2011, London UK Head-to-head study primary end point did not meet Read more...

XenoPort to Present at the 23rd Annual Piper Jaffray Health Care Conference

Posted November 15, 2011

SANTA CLARA, Calif.--(BUSINESS WIRE)-- XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 23rd Annual Piper Jaffray Health Read more...

ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthri

Posted November 8, 2011

Results Presented in Late-Breaker Oral Presentation at the Annual Meeting of the American College of Rheumatology (ACR)MOUNTAIN VIEW, Calif., Nov. 8, 2011 /PRNewswire/ -- ChemoCentryx, Inc., today Read more...

Prosensa Named Most Innovative European Biotech SME

Posted November 8, 2011

Company wins prestigious EuropaBio Award LEIDEN, Netherlands--(BUSINESS WIRE)-- Prosensa, the Dutch biopharmaceutical company focusing on rare diseases with a high unmet medical need, has won Read more...

Seattle Genetics to Present at Two Upcoming Investor Conferences

Posted November 7, 2011

BOTHELL, Wash.--(BUSINESS WIRE)-- Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the following upcoming investor conferences. Credit Suisse Healthcare Read more...

Anacor Pharmaceuticals Announces Third Quarter 2011 Financial Results Conference Call and Webcast

Posted November 3, 2011

PALO ALTO, Calif.--(BUSINESS WIRE)-- Anacor Pharmaceuticals (NASDAQ:ANAC) will release its financial results for the third quarter ended September 30, 2011, on Thursday November 10, 2011 at Read more...

XenoPort to Present at the Credit Suisse Healthcare Conference

Posted November 3, 2011

SANTA CLARA, Calif.--(BUSINESS WIRE)-- XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2011 Credit Suisse Healthcare Read more...